Impact of Antibodies and Strain Polymorphisms on Cytomegalovirus Entry and Spread in Fibroblasts and Epithelial Cells

• Published in: Journal of virology Vol. 91; no. 13
• Main Authors: Cui, Xiaohong, Freed, Daniel C, Wang, Dai, Qiu, Ping, Li, Fengsheng, Fu, Tong-Ming, Kauvar, Lawrence M, McVoy, Michael A
• Format: Journal Article
• Language: English
• Published: United States American Society for Microbiology 01-07-2017
• Subjects: Antibodies, Neutralizing - immunology; Antibodies, Viral - immunology; Cell Line; Cytomegalovirus - immunology; Cytomegalovirus - physiology; Epithelial Cells - virology; Fibroblasts - virology; Humans; Vaccines and Antiviral Agents; Viral Envelope Proteins - immunology; Virus Internalization; fusion; cytomegalovirus; neutralization; virus entry; neutralizing antibodies; antibodies; polymorphisms; spread
• ISSN: 0022-538X; 1098-5514
• DOI: 10.1128/jvi.01650-16

Cytomegalovirus (CMV) entry into fibroblasts differs from entry into epithelial cells. CMV also spreads cell to cell and can induce syncytia. To gain insights into these processes, 27 antibodies targeting epitopes in CMV virion glycoprotein complexes, including glycoprotein B (gB), gH/gL, and the pentamer, were evaluated for their effects on viral entry and spread. No antibodies inhibited CMV spread in fibroblasts, including those with potent neutralizing activity against fibroblast entry, while all antibodies that neutralized epithelial cell entry also inhibited spread in epithelial cells and a correlation existed between the potencies of these two activities. This suggests that exposure of virions to the cell culture medium is obligatory during spread in epithelial cells but not in fibroblasts. In fibroblasts, the formation of syncytiumlike structures was impaired not only by antibodies to gB or gH/gL but also by antibodies to the pentamer, suggesting a potential role for the pentamer in promoting fibroblast fusion. Four antibodies reacted with linear epitopes near the N terminus of gH, exhibited strain specificity, and neutralized both epithelial cell and fibroblast entry. Five other antibodies recognized conformational epitopes in gH/gL and neutralized both fibroblast and epithelial cell entry. That these antibodies were strain specific for neutralizing fibroblast but not epithelial cell entry suggests that polymorphisms external to certain gH/gL epitopes may influence antibody neutralization during fibroblast but not epithelial cell entry. These findings may have implications for elucidating the mechanisms of CMV entry, spread, and antibody evasion and may assist in determining which antibodies may be most efficacious following active immunization or passive administration.
Cytomegalovirus (CMV) is a significant cause of birth defects among newborns infected
and morbidity and mortality in transplant and AIDS patients. Monoclonal antibodies and vaccines targeting humoral responses are under development for prophylactic or therapeutic use. The findings reported here (i) confirm that cell-to-cell spread of CMV is sensitive to antibody inhibition in epithelial cells but not fibroblasts, (ii) demonstrate that antibodies can restrict the formation
of syncytiumlike structures that resemble syncytial cytomegalic cells that are associated with CMV disease
, and (iii) reveal that neutralization of CMV by antibodies to certain epitopes in gH or gH/gL is both strain and cell type dependent and can be governed by polymorphisms in sequences external to the epitopes. These findings serve to elucidate the mechanisms of CMV entry, spread, and antibody evasion and may have important implications for the development of CMV vaccines and immunotherapeutics.